

Neuroprotect


Objectives
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)

OUR ACHIEVEMENTS
Approved by Startup Pará, Catalisa, Inova Amazônia. Was a finalist in Biotechtown, Emerge Amazônia, Emerge Biodiversidade. Represented Pará in the Sebrae Like a Boss challenge, Bossa Summit, Florianópolis Summit, Amazônia Summit. Approved project at Embrapii together with the largest drug developer in Brazil, in the pre-clinical phase, Cienp, from Florianópolis.




CEO
Dr. Walace Gomes Leal
PhD, biomedical scientist, master's degree in Biological Sciences, concentration area Neurosciences. He is a CNPQ research productivity fellow. He completed post-doctorate studies at the Wallenberg Neuroscience Center, Section of Restorative Neurology, at Lund University, Sweden. He completed post-doctorate studies at the University of California, San Diego (United States). He is an undergraduate professor (Associate IV) at the Institute of Public Health of the Federal University of Western Pará (UFOPA) and post-graduate (Neurosciences and Cell Biology, Oncology and Medical Sciences) at the Institute of Biological Sciences of the Federal University of Pará. Consultant for the CNPQ, Ministry of Health, Ibero-American Council for Science and Technology, Foundation for Support and Development of Research of Rio Grande do Norte (FAPERN).